研報掘金丨浙商證券:申通快遞盈利能力有望提升,上調至“買入”評級
浙商證券研報指出,申通快遞(002468.SH)1月快遞件量躍居第三,進入發展新階段,2025年盈利彈性有望加速兌現。判斷25 年的行業件量增速中樞仍有望保持在雙位數,快遞行業景氣度持續向好。2025年申通一年一度的管理者新春啓動會上,總裁王文彬表示“不追隨、敢超越,做精做深做強,2025年申通的核心目標就是提升客戶服務體驗,超越行業固有標準”。考慮2024年行業件量增速持續超預期,申通快遞受益於產能提升,公司業務量快速增長,市佔率有望逐步提升,疊加規模效應釋放,盈利能力有望提升。上調至“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.